Evercore ISI upgraded Apellis Pharmaceuticals to a “strong-buy” rating in a research note published on Thursday.
Apellis Pharmaceuticals (NASDAQ:APLS) received a strong-buy rating from Evercore ISI. Read More »
Evercore ISI upgraded Apellis Pharmaceuticals to a “strong-buy” rating in a research note on Thursday.
S&P Futures Slightly Higher: S&P futures are up 0.1% in Monday morning trading, following a strong performance last week where all major indexes rose over 1%. Mag 7 tech stocks and banks were among the top gainers. Treasuries were narrowly mixed, with the 2/10 yield curve steepening to its highest level since June 2022. The
ETFsector.com Daily Trading Outlook, September 23, 2024 Read More »
The article examines the top 10 mid-cap healthcare stocks currently worth investing in. It discusses growth projections, challenges, and technological innovations in the global healthcare market.
Top 10 healthcare stocks with a mid-cap size to consider investing in. Read More »
Related stocks include NAS:APLS.
Q2 2024 Apellis Pharmaceuticals Inc Earnings Call Transcript Read More »
Stay updated with the latests analysis and insights fromm etfsector.com